2m 2m 2m 2m 2m 2m 2m
Ligand Pharma (LGND)
NASDAQ
$286.55+$2.08 (+0.73%)
Price as of Sep 11, 2026 7:58 PM EDT- $5.7BMarket Cap
- 71.63%1-Year Change
- BiotechnologyIndustry
Ligand Pharma (LGND)
$286.55+$2.08 (+0.73%)
Earnings Score
Valuation | LGND | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | LGND | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 20.55% | ||
12-Month Momentum | 75.55% | ||
3-Month Risk Adjusted Momentum | 127.69% | ||
12-Month Risk Adjusted Momentum | 212.77% |
True Yield
Valuation | LGND | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.95% | ||
Net Debt Paydown Yield | -8.89% |
Financial Health Score
Valuation | LGND | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 7 |